Antiplatelet Effect of Clopidogrel Can Be Reduced by Calcium-Channel Blockers

PURPOSE: Clopidogrel is metabolized by the hepatic cytochrome P450 (CYP) system into its active thiol metabolite. CYP3A4 is involved in the metabolism of both clopidogrel and dihydropyridine calcium channel blockers (CCBs). A few reports have suggested an inhibitory interaction between CCBs and clop...

Descripción completa

Detalles Bibliográficos
Autores principales: Seo, Kwon-Duk, Kim, Young Dae, Yoon, Young-Won, Kim, Jong-Youn, Lee, Kyung-Yul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Yonsei University College of Medicine 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990098/
https://www.ncbi.nlm.nih.gov/pubmed/24719135
http://dx.doi.org/10.3349/ymj.2014.55.3.683

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990098/
https://www.ncbi.nlm.nih.gov/pubmed/24719135
http://dx.doi.org/10.3349/ymj.2014.55.3.683

Ejemplares similares